| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer | President and CEO
3 companies
Southwell David P is a Director at RCKT, with reported holdings spanning 3 companies. Recent filings cover 4 purchases and 19 sales. Those positions are worth an estimated $609K at current prices.
Our model assigns Southwell David P a middling insider score of 65/100, based on 8 past trades. Over a 12-month horizon, 62.5% of those trades were profitable, with an average 12-month return of +24.9%.
Southwell David P's largest disclosed position is in TCRX as Chief Executive Officer, worth about $609K. Net of sales, the recent Form 4 record there shows accumulation of 36,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2017 | RCKT Rocket Pharmaceuticals, Inc. | President and CEO | Buy | 60,000 | $1.75 | $105,000.00 | +2,170% | |
| Jul 6, 2015 | PTCT Ptc Therapeutics, Inc. | Director | Sale+OE | 23,604 | $47.52 | $1,121,694.00 | - |